The Medicine Maker | The Medicine Maker

Biopharma Labs Have an Integration Debt Problem

August 17, 2026

Biopharma labs are investing heavily in digital tools, but without trusted data architecture, each new platform can add another point of failure

5 min read

Cell & Gene

This Week’s CGT News: T-Cell Therapy Clears Pediatric Solid Tumor

PRAME-targeted T cells produce a complete response in metastatic nephroblastoma, CAR T cells remain active after a decade, and an in vivo CRISPR screen identifies edits that strengthen solid-tumor activity

Cell & Gene

Musings from The Power List: John Maher

John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors

Cell & Gene

Why Cell Therapy Needs a Digital Backbone

Alexander Seyf on why the UK is losing ground in cell and gene therapy, the real bottlenecks to commercialization, and why digitalization is no longer optional

Drug Discovery

Can Exosomes Unlock Nanomedicine’s Regenerative Medicine Potential?

NurExone CEO Lior Shaltiel discusses the company’s exosome-based approach to nerve regeneration, the manufacturing hurdles facing the field, and what it will take to bring nanotechnology therapeutics to patients

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Small Molecules Drug Discovery Power List

Musings from The Power List: Ann Cleves

August 11, 2026

Ann Cleves on why the future of small-molecule drug discovery lies beyond the rule of five

3 min read

Cell & Gene Interviews Business & Trends Technology & Manufacturing

Building Commercial Readiness in Advanced Therapies

August 10, 2026

Why early process development, analytical planning, and tech transfer can shape the future of cell and gene therapy manufacturing

5 min read

Cell & Gene Industry News Research News

This Week’s CGT News: In Vivo CAR T Draws Major Investment

August 10, 2026

Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes

3 min read

Outsourcing Biopharma Business & Trends

Musings from The Power List: Ali Pashazadeh

August 7, 2026

Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier

7 min read

Biopharma Interviews Technology & Manufacturing

Moving Glycosylation Control Upstream

August 6, 2026

Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.

7 min read

Development & Clinical Future of Pharma Technology & Manufacturing

What Did ASCO 2026 Reveal About the Future of Oncology?

August 6, 2026

Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades

8 min read

Development & Clinical Biopharma Interviews Business & Trends

How China Is Rewriting the Rules Global Drug Development

August 5, 2026

In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development

14 min read

Supply Chain Business & Trends Future of Pharma

Do Pharma Supply Chains Have a Visibility Problem?

August 4, 2026

A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain

4 min read

Development & Clinical Business & Trends Biopharma

The 10 Biggest Bottlenecks Slowing Drug Development

August 4, 2026

Ten industry leaders from the 2026 Power List identify the scientific, clinical, regulatory, and financial barriers holding drug development back

6 min read

Cell & Gene Drug Discovery Research News Development & Clinical Regulation & Standards

This Week’s CGT News: Gene-Editing Trial Death Raises Concerns

August 3, 2026

A previously undisclosed death in China raises questions about gene-editing oversight, deramiocel meets its Phase 3 Duchenne endpoint, and researchers identify a source of CAR NK dysfunction

4 min read

Top Stories